This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
J&J partners with Anchor on GPCR-based therapeutics
04 Oct 2011
A month after closing its $10mm Series B round, Anchor Therapeutics Inc. (developing GPCR-targeting compounds) has now agreed to use its Pepducin technology to help Johnson & Johnson's Ortho-McNeil-Janssen Pharmaceuticals Inc. discover drug candidates for cancer and metabolic disorders.
R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?